Business Description
Medeze Group PCL
ISIN : THC430010007
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 21.76 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.06 | |||||
Interest Coverage | 20.14 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.22 | |||||
9-Day RSI | 36.95 | |||||
14-Day RSI | 34.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.45 | |||||
Quick Ratio | 2.33 | |||||
Cash Ratio | 1.92 | |||||
Days Inventory | 71.58 | |||||
Days Sales Outstanding | 35.2 | |||||
Days Payable | 27.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.02 | |||||
Forward Dividend Yield % | 4.08 | |||||
5-Year Yield-on-Cost % | 1.02 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 78.5 | |||||
Operating Margin % | 43.88 | |||||
Net Margin % | 36.12 | |||||
FCF Margin % | 27.56 | |||||
ROE % | 21.46 | |||||
ROA % | 12.58 | |||||
ROIC % | 16.42 | |||||
ROC (Joel Greenblatt) % | 72.44 | |||||
ROCE % | 18.58 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 56.97 | |||||
PE Ratio without NRI | 56.97 | |||||
PS Ratio | 20.52 | |||||
PB Ratio | 11.43 | |||||
Price-to-Tangible-Book | 11.57 | |||||
Price-to-Free-Cash-Flow | 74.52 | |||||
Price-to-Operating-Cash-Flow | 54.2 | |||||
EV-to-EBIT | 43.14 | |||||
EV-to-EBITDA | 40.48 | |||||
EV-to-Revenue | 20 | |||||
EV-to-FCF | 71.53 | |||||
Price-to-Graham-Number | 5.42 | |||||
Earnings Yield (Greenblatt) % | 2.3 | |||||
FCF Yield % | 1.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medeze Group PCL Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ฿) | 403.609 | ||
EPS (TTM) (฿) | 0.136 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 34.81 | ||
14-Day ATR (฿) | 0.433082 | ||
20-Day SMA (฿) | 8.0575 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (฿) | 7.45 - 13.8 | ||
Shares Outstanding (Mil) | 1,068 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medeze Group PCL Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medeze Group PCL Stock Events
Event | Date | Price(฿) | ||
---|---|---|---|---|
No Event Data |
Medeze Group PCL Frequently Asked Questions
What is Medeze Group PCL(BKK:MEDEZE)'s stock price today?
When is next earnings date of Medeze Group PCL(BKK:MEDEZE)?
Does Medeze Group PCL(BKK:MEDEZE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |